Majority shareholder approves up to 60-for-1 reverse stock split

Sunshine Biopharma Inc.

Dr. Steve Slilaty, holding 84.8% voting power, approved reverse split by written consent.
Reverse split ratio up to 60-for-1 of common stock.
Effective 20 days after mailing definitive information statement to shareholders.
Dr. Slilaty is CEO and controls majority voting power.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.